Levels of cotinine in dried blood specimens from newborns as a biomarker of maternal smoking close to the time of delivery

American Journal of Epidemiology

Volumn 178, Issue 11, 2013, Pages 1648-1654

  Yang, Juan ^a   Pearl, Michelle ^a   Jacob III, Peyton ^b   DeLorenze, Gerald N ^c   Benowitz, Neal L ^b   Yu, Lisa ^b   Havel, Christopher ^b   Kharrazi, Martin ^a  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DIVISION OF RESEARCH   (United States)

Author keywords

Cotinine; Dried blood spot; Maternal smoking; Newborn; Pregnancy

Indexed keywords

COTININE;

BIOMARKER; BLOOD; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PREGNANCY; SMOKING;

ADULT; ARTICLE; BLOOD LEVEL; DISEASE ASSOCIATION; DRIED BLOOD SPOT TESTING; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MATERNAL SMOKING; MEASUREMENT ACCURACY; NATURAL CHILDBIRTH; NEWBORN; NEWBORN SCREENING; NORMAL HUMAN; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; UMBILICAL CORD BLOOD;

COTININE; DRIED BLOOD SPOT; MATERNAL SMOKING; NEWBORN; PREGNANCY;

ADULT; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; COTININE; DRIED BLOOD SPOT TESTING; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; LINEAR MODELS; MATERNAL BEHAVIOR; PREGNANCY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SMOKING; TANDEM MASS SPECTROMETRY;

CALIFORNIA; UNITED STATES;

EID: 84890017934     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwt182     Document Type: Article

References (31)

1. U.S. Department of Health and Human Services. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2010.
2. U.S. Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004.
3. Pichini S, Basagana X, Pacifici R, et al. Cord serum cotinine as a biomarker of fetal exposure to cigarette smoke close to delivery. Environ Health Perspect. 2000;108(11): 1079-1083.
4. Florescu A, Ferrence R, Einarson TR, et al. Reference values for hair cotinine as biomarker of active and passive smoking in women of reproductive age, pregnant women, children, and neonates: Systematic review and meta-analysis. Ther Drug Monit. 2007;29(4):437-446.
5. Patrick DL, Cheadle A, Thompson DC, et al. The validity of self-reported smoking: A review and meta-analysis. Am J Public Health. 1994;84(7):1086-1093.
6. Al-Delaimy WK,Woodward JA. Is the hair nicotine level a more accurate biomarker of environmental tobacco smoke exposure than urine cotinine J Epidemiol Community Health. 2002;56(1):66-71.
7. Florescu A, Ferrence R, Einarson T, et al. Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: Focus on developmental toxicology. Ther Drug Monit. 2009;31(1):14-30.
8. Etter JF, Duc TV, Perneger TV. Saliva cotinine levels in smokers and nonsmokers. Am J Epidemiol. 2000;151(3): 251-258.
9. Al-Delaimy WK, Crane J,Woodward A. Questionnaire and hair measurement of exposure to tobacco smoke. J Expo Anal Environ Epidemiol. 2000;10(4):378-384.
10. Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev. 1996;18(2):188-204.
11. Perez-Stable EJ, Benowitz NL, Marin G. Is serum cotinine a better measure of cigarette smoking than self-report Prev Med. 1995;24(2):171-179.
12. Abrams DB, Follick MJ, Biener L, et al. Saliva cotinine as a measure of smoking status in field settings. Am J Public Health. 1987;77(7):846-848.
13. Britton GR, Brinthaupt J, Stehle JM, et al. Comparison of self-reported smoking and urinary cotinine levels in a rural pregnant population. J Obstet Gynecol Neonatal Nurs. 2004;33(3):306-311.
14. Chan D, Caprara D, Blanchette P, et al. Recent developments in meconium and hair testing methods for the confirmation of gestational exposures to alcohol and tobacco smoke. Clin Biochem. 2004;37(6):429-438.
15. Eliopoulos C, Klein J, Phan MK, et al. Hair concentrations of nicotine and cotinine in women and their newborn infants. JAMA. 1994;271(8):621-623.
16. Ostrea EM Jr, Knapp DK, Romero A, et al. Meconium analysis to assess fetal exposure to nicotine by active and passive maternal smoking. J Pediatr. 1994;124(3):471-476.
17. Olney RS, Moore CA, Ojodu JA, et al. Storage and use of residual dried blood spots from state newborn screening programs. J Pediatr. 2006;148:618-622.
18. Hannon WH, Boyle J, Davin B, et al. Blood Collection on Filter Paper for Neonatal Screening Erograms, 3rd Edition, Approved Standard, National Committee for Clinical Laboratory Standards Document A4A3.Wayne, PA: National Committee for Clinical Laboratory Standards; 1997.
19. Mei JV, Alexander JR, Adam BW, et al. Use of filter paper for the collection and analysis of human whole blood specimens. J Nutr. 2001;131(5 suppl):1631S-1636S.
20. Sosnoff CS, Bernert JT. Analysis of cotinine in dried blood spots by LC APCI tandem mass spectrometry. Clin Chim Acta. 2008;388(1-2):228-229.
21. Spector LG, Hecht SS, Ognjanovic S, et al. Detection of cotinine in newborn dried blood spots. Cancer Epidemiol Biomarkers Prev. 2007;16(9):1902-1905.
22. Kharrazi M, Pearl M, Yang J, et al. Evaluation of two birth certificate smoking questions [abstract]. Am J Epidemiol. 2008;167(11 suppl):S35.
23. Cunningham GC, Tompkinson DG. Cost and effectiveness of the California Triple Marker Prenatal Screening Program. Genet Med. 1999;1(5):199-206.
24. Kharrazi M, Pearl M, Yang J, et al. California Very Preterm Birth Study: Design and characteristics of a population-and biospecimen bank-based nested case-control study. Paediatr Perinat Epidemiol. 2012;26(3):250-263.
25. Jacob P 3rd, Yu L, Duan M, et al. Determination of the nicotine metabolites cotinine and trans-3-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: Biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity. J Chromatogr B Analyt Technol Biomed Life Sci. 2011;879(3-4):267-276.
26. Watts RR, Langone JJ, Knight GJ, et al. Cotinine Analytical Workshop report: Consideration of analytical methods for determining cotinine in human body fluids as a measure of passive exposure to tobacco smoke. Environ Health Perspect. 1990;84:173-182.
27. Dempsey D, Jacob P III, Benowitz NL. Nicotine metabolism and elimination kinetics in newborns. Clin Pharmacol Ther. 2000;67(5):458-465.
28. Benowitz NL, Bernert JT, Caraballo RS, et al. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am J Epidemiol. 2009;169(2): 236-248.
29. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 2002;4(2):149-159.
30. Dempsey D, Jacob P III, Benowitz NL. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther. 2002;301(2):594-598.
31. Olshan AF. Meeting report: The use of newborn blood spots in environmental research: Opportunities and challenges. Environ Health Perspect. 2007;115(12):1767-1779.